Author:
Losa R.,Fra J.,López-Pousa A.,Sierra M.,Goitia A.,Uña E.,Nadal R.,del Muro J. García,Gión M.,Maurel J.,Escudero P.,Esteban E.,Buesa José M.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference39 articles.
1. Abbruzzese JL, Grunewald R, Weeks EA, Gravel D, Adams T, Nowak B, Mineishi S, Tarassoff P, Satterlee W, Raber MN (1991) Phase I clinical, plasma, and cellular pharmacology study of gemcitabine. J Clin Oncol 9:491–498
2. Amodio A, Carpano S, Manfredi C, Del Monte G, Di Lauro L, Gionfra T, Conti F, Paoletti G, Lopez M (1999) Gemcitabine in advanced stage soft tissue sarcoma: a phase II study. Clin Ther 150:17–20
3. Beauséjour CM, Gagnon J, Primeau M, Momparler RL (2002) Cytotoxic activity of 2′,2′-difluorodeoxycytidine, 5-aza-2′-deoxycytidine and cytosine arabinoside in cells transduced with deoxycytidine kinase gene. Biochem Biophys Res Commun 293:1478–1484
4. Brennan MF, Singers S, Maki RG, O’Sullivan B (2005) Soft-tissue sarcoma. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology. Lippincott Williams and Wilkins, Philadelphia, pp 1581–1637
5. Buesa JM, Mouridsen HT, van Oosterom AT, Verweij J, Wagener T, Steward W, Poveda A, Vestlev PM, Thomas D, Sylvester (1991) High-dose DTIC in advanced soft-tissue sarcomas in the adult. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Ann Oncol 2:307–309
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献